Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Cistanche deserticola glycosides** refers to a mixture of glycosides, predominantly phenylethanoid glycosides, extracted from the desert plant Cistanche deserticola, a notable traditional Chinese medicinal herb. The most abundant and biologically active glycosides in this extract are echinacoside and acteoside, along with others such as tubuloside A/B and isoacteoside. These compounds have demonstrated several pharmacological effects, including anti-inflammatory, antioxidant, and hepatoprotective actions. Cistanche deserticola glycosides have also shown neuroprotective and vasoprotective effects, improving outcomes in preclinical models of ischemic stroke and atherosclerosis, primarily via modulation of pathways such as Nrf2/Keap1 and PPARγ-LXRα-ABCA1. There are ongoing studies exploring their effect on neurological, hepatic, and cardiovascular diseases, but no approval for pharmaceutical indications outside of use as a traditional or dietary supplement in some countries[3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cistanche deserticola glycosides.